Latest Articles

Article Type

Open Access
Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction
Qiang Ma
John Schuetz, ASSOCIATE EDITOR

Pharmacological Reviews May 2023, 75 (3) 487-520; DOI: https://doi.org/10.1124/pharmrev.122.000629
Open Access
G Protein-Coupled Receptor Pharmacology—Insights from Mass Spectrometry
Hsin-Yung Yen, Ali Jazayeri and Carol V. Robinson
Gunnar Schulte, ASSOCIATE EDITOR

Pharmacological Reviews May 2023, 75 (3) 397-415; DOI: https://doi.org/10.1124/pharmrev.120.000237
Open Access
Pharmacology of Heparin and Related Drugs: An Update
John Hogwood, Barbara Mulloy, Rebeca Lever, Elaine Gray and Clive P. Page
Lynette Daws, ASSOCIATE EDITOR

Pharmacological Reviews March 2023, 75 (2) 328-379; DOI: https://doi.org/10.1124/pharmrev.122.000684
You have access
Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications
Hedieh Shahpasand-Kroner, Ibrar Siddique, Ravinder Malik, Gabriel R. Linares, Magdalena I. Ivanova, Justin Ichida, Tatjana Weil, Jan Münch, Elsa Sanchez-Garcia, Frank-Gerrit Klärner, Thomas Schrader and Gal Bitan
Habibeh Khoshbouei, ASSOCIATE EDITOR

Pharmacological Reviews March 2023, 75 (2) 263-308; DOI: https://doi.org/10.1124/pharmrev.122.000654
Open Access
Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood
Fulton T. Crews, Leon G. Coleman, Victoria A. Macht and Ryan P. Vetreno
Robert Dantzer, ASSOCIATE EDITOR

Pharmacological Reviews March 2023, 75 (2) 380-396; DOI: https://doi.org/10.1124/pharmrev.122.000710
You have access
Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
Edris Choupani, Mohammad Mahmoudi Gomari, Saeed Zanganeh, Sherko Nasseri, Kaveh Haji-allahverdipoor, Neda Rostami, Yaeren Hernandez, Safa Najafi, Neda Saraygord-Afshari and Arshad Hosseini
Michael Gottesman, ASSOCIATE EDITOR

Pharmacological Reviews March 2023, 75 (2) 309-327; DOI: https://doi.org/10.1124/pharmrev.122.000665
You have access
Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease
Kristan H. Cleveland and Rick G. Schnellmann
John Schuetz, ASSOCIATE EDITOR

Pharmacological Reviews March 2023, 75 (2) 250-262; DOI: https://doi.org/10.1124/pharmrev.122.000560
You have access
Sex/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect
Eleanor Blair Towers, Ivy L. Williams, Emaan I. Qillawala, Emilie F. Rissman and Wendy J. Lynch
Michael Nader, ASSOCIATE EDITOR

Pharmacological Reviews March 2023, 75 (2) 217-249; DOI: https://doi.org/10.1124/pharmrev.121.000361
Open Access
Dopamine, Immunity, and Disease
Breana Channer, Stephanie M. Matt, Emily A. Nickoloff-Bybel, Vasiliki Pappa, Yash Agarwal, Jason Wickman and Peter J. Gaskill
Habibeh Khoshbouei, ASSOCIATE EDITOR

Pharmacological Reviews January 2023, 75 (1) 62-158; DOI: https://doi.org/10.1124/pharmrev.122.000618
You have access
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer
Al-Hassan M. Mustafa and Oliver H. Krämer
Lynette Daws, ASSOCIATE EDITOR

Pharmacological Reviews January 2023, 75 (1) 35-61; DOI: https://doi.org/10.1124/pharmrev.122.000612

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals